Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Jin Medical International (ZJYL) Competitors

Jin Medical International logo
$2.28 -0.10 (-4.20%)
Closing price 05/19/2026 04:00 PM Eastern
Extended Trading
$2.28 +0.00 (+0.04%)
As of 05/19/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ZJYL vs. LNSR, BDMD, OM, APT, and NSPR

Should you buy Jin Medical International stock or one of its competitors? MarketBeat compares Jin Medical International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jin Medical International include LENSAR (LNSR), Baird Medical Investment (BDMD), Outset Medical (OM), Alpha Pro Tech (APT), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.

How does Jin Medical International compare to LENSAR?

Jin Medical International (NASDAQ:ZJYL) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

In the previous week, LENSAR had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for LENSAR and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 equaled LENSAR'saverage media sentiment score.

Company Overall Sentiment
Jin Medical International Neutral
LENSAR Neutral

LENSAR has a consensus price target of $10.00, suggesting a potential upside of 72.41%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Jin Medical International has a beta of 7.52, meaning that its stock price is 652% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market.

40.2% of LENSAR shares are owned by institutional investors. 66.0% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Jin Medical International has higher earnings, but lower revenue than LENSAR.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.86$1.19MN/AN/A
LENSAR$58.44M1.20-$34.28M-$0.58N/A

LENSAR has a net margin of 50.94% compared to Jin Medical International's net margin of 0.00%. Jin Medical International's return on equity of 0.00% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
LENSAR 50.94%-183.19%42.26%

Summary

LENSAR beats Jin Medical International on 10 of the 13 factors compared between the two stocks.

How does Jin Medical International compare to Baird Medical Investment?

Jin Medical International (NASDAQ:ZJYL) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Jin Medical International has a beta of 7.52, indicating that its share price is 652% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.18, indicating that its share price is 218% less volatile than the broader market.

In the previous week, Jin Medical International's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Jin Medical International Neutral
Baird Medical Investment Neutral

19.8% of Baird Medical Investment shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Baird Medical Investment N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Jin Medical International has higher earnings, but lower revenue than Baird Medical Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.86$1.19MN/AN/A
Baird Medical Investment$22.54M2.98N/AN/AN/A

Summary

Baird Medical Investment beats Jin Medical International on 4 of the 5 factors compared between the two stocks.

How does Jin Medical International compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Outset Medical has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.52, indicating that its stock price is 652% more volatile than the broader market.

In the previous week, Outset Medical had 5 more articles in the media than Jin Medical International. MarketBeat recorded 5 mentions for Outset Medical and 0 mentions for Jin Medical International. Outset Medical's average media sentiment score of 0.13 beat Jin Medical International's score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company Overall Sentiment
Outset Medical Neutral
Jin Medical International Neutral

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 159.07%. Given Outset Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Outset Medical is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Jin Medical International has lower revenue, but higher earnings than Outset Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.48M0.60-$81.65M-$4.16N/A
Jin Medical International$20.69M0.86$1.19MN/AN/A

Jin Medical International has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Jin Medical International's return on equity of 0.00% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-63.65% -56.13% -27.45%
Jin Medical International N/A N/A N/A

Summary

Outset Medical and Jin Medical International tied by winning 6 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to Alpha Pro Tech?

Jin Medical International (NASDAQ:ZJYL) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Jin Medical International has a beta of 7.52, suggesting that its stock price is 652% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Alpha Pro Tech has a net margin of 6.99% compared to Jin Medical International's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Alpha Pro Tech 6.99%6.70%5.76%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Pro Tech has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.86$1.19MN/AN/A
Alpha Pro Tech$59.91M1.03$4.19M$0.3517.20

In the previous week, Alpha Pro Tech had 5 more articles in the media than Jin Medical International. MarketBeat recorded 5 mentions for Alpha Pro Tech and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat Alpha Pro Tech's score of -0.07 indicating that Jin Medical International is being referred to more favorably in the media.

Company Overall Sentiment
Jin Medical International Neutral
Alpha Pro Tech Neutral

22.7% of Alpha Pro Tech shares are held by institutional investors. 15.0% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Alpha Pro Tech beats Jin Medical International on 9 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to InspireMD?

InspireMD (NYSE:NSPR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

InspireMD has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.52, meaning that its stock price is 652% more volatile than the broader market.

Jin Medical International has higher revenue and earnings than InspireMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InspireMD$10.85M4.32-$19.92M-$0.73N/A
Jin Medical International$20.69M0.86$1.19MN/AN/A

Jin Medical International has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Jin Medical International's return on equity of 0.00% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
InspireMD-413.96% -69.42% -57.68%
Jin Medical International N/A N/A N/A

44.8% of InspireMD shares are held by institutional investors. 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

InspireMD currently has a consensus price target of $4.50, suggesting a potential upside of 350.00%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InspireMD
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, InspireMD had 6 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for InspireMD and 0 mentions for Jin Medical International. InspireMD's average media sentiment score of 1.08 beat Jin Medical International's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company Overall Sentiment
InspireMD Positive
Jin Medical International Neutral

Summary

InspireMD beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

Export
MetricJin Medical InternationalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$18.59M$8.31B$6.25B$12.23B
Dividend YieldN/A2.53%2.80%5.32%
P/E RatioN/A15.9920.7925.05
Price / Sales0.868.04531.2172.69
Price / Cash12.9616.9143.0954.25
Price / Book0.603.939.816.83
Net Income$1.19M$224.05M$3.55B$335.69M
7 Day Performance-6.94%-1.95%-2.12%-2.15%
1 Month Performance4.83%-4.26%-4.14%-2.47%
1 Year Performance-85.57%-1.03%28.34%27.13%

Jin Medical International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
N/A$2.28
-4.2%		N/A-85.9%$18.59M$20.69MN/A245
LNSR
LENSAR
1.5041 of 5 stars		$5.88
+1.7%		$10.00
+70.1%		-58.9%$69.96M$58.44MN/A110
BDMD
Baird Medical Investment
N/A$1.71
+1.8%		N/A-68.0%$68.85M$22.54MN/AN/A
OM
Outset Medical
2.0994 of 5 stars		$3.84
+5.2%		$10.00
+160.4%		-80.3%$67.66M$119.48MN/A520
APT
Alpha Pro Tech
N/A$6.35
-4.4%		N/A+36.5%$64.88M$59.91M17.16120

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ZJYL) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...
Profits Run | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
He doesn't buy gold. He just profits from it.
Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...
Brownstone Research | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel